RA PHARMACEUTICALS INC - COM (RARX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2016 to Q3 2020

Type / Class
Equity / COM
Symbol
RARX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of RA PHARMACEUTICALS INC - COM (RARX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q3 0 $0 -$32,000 0
2020 Q2 266 $32,000 -$2,442,548,332 $120.30 1
2020 Q1 51,413,337 $2,468,129,570 +$75,022,522 $48.01 143
2019 Q4 50,020,039 $2,347,432,583 +$325,865,602 $46.93 145
2019 Q3 48,303,621 $1,142,387,415 +$116,671,176 $23.65 117
2019 Q2 43,066,544 $1,285,227,690 +$141,390,796 $30.07 118
2019 Q1 40,180,717 $900,042,604 +$50,321,039 $22.40 122
2018 Q4 33,102,957 $602,472,946 +$186,544,211 $18.20 93
2018 Q3 24,217,413 $438,101,967 +$16,982,506 $18.09 69
2018 Q2 23,389,635 $232,732,522 -$3,029,256 $9.95 61
2018 Q1 24,389,410 $129,513,925 +$46,025,265 $5.31 73
2017 Q4 15,448,326 $131,308,412 -$9,272,150 $8.50 64
2017 Q3 15,752,758 $230,010,900 +$9,684,512 $14.60 62
2017 Q2 14,981,354 $280,753,156 +$16,983,060 $18.74 65
2017 Q1 13,949,727 $296,989,490 +$12,266,834 $21.29 61
2016 Q4 14,100,880 $214,196,000 +$214,196,001 $15.19 58